Actinogen Medical LimitedASX: ACW

Notification of buy-back - ACW

Oct 11, 2026 at 9:41 PM EDT · Issued by Actinogen Medical Limited via ASX

Filed with ASX · Oct 11, 2026 at 9:41 PM EDT · 5 pages · English

On 6ix: 6ix.com/news/notification-of-buy-back-acw

Release

Appendix 3C - Notification of buy-backAppendix 3C - Notification of buy-back1 / 5Announcement SummaryName of entityACTINOGEN MEDICAL LIMITEDAnnouncement typeNew announcementDate of this announcement12/10/2026ASX Security code and description of the class of +securities the subject of the...

Actinogen Medical Limited on 6ix

Earlier from Actinogen Medical

AGM date and closing date for director nominationsOct 8
Application for quotation of securities - ACWSep 29
Actinogen XanaMIA pivotal Alzheimer’s disease trial completes final patient visit, with topline results on track for NovemberSep 23
Underwriting of unlisted options completedSep 22
Options underwriting cleansing noticeSep 22

Later from Actinogen Medical

ACW September 2026 quarterly activity report & Appendix 4COct 18
ACW pivotal Alzheimers trial database lock - results mid-NovOct 20
Actinogen receives $10.8m R&D tax incentive rebate from ATOOct 25
Letter to Shareholders, Notice of AGM & Proxy FormOct 27

All Actinogen Medical news releases

Follow Actinogen Medical into a list and get an email when it puts out news.

Follow Actinogen Medical